食管切除术后吻合口瘘对长期生存的影响:ALES多中心队列研究
该国际多中心队列研究纳入2018-2023年17家欧洲高容量中心2905例接受新辅助CROSS或FLOT后食管切除术的食管或交界部癌患者,按ECCG分级评估吻合口瘘严重程度对长期生存的影响。结果显示需外科再干预的III型瘘与30天和90天死亡率升高及中位总生存期显著缩短相关,多变量调整后死亡风险增加。
要点
- III型吻合口瘘(需外科再干预)与长期生存受损独立相关。
- 保守或无外科干预的吻合口瘘未观察到显著生存缺陷。
- 吻合口瘘患者辅助治疗实施率较低。
核心结论
- 需外科再干预的吻合口瘘与食管切除术后生存受损相关,构成高风险临床特征。
研究设计与样本
- 国际多中心队列研究,纳入17家欧洲高容量中心2018-2023年接受新辅助CROSS或FLOT后食管切除术的成人食管或交界部癌患者2905例。
主要发现
- 425例(14.6%)发生吻合口瘘,吻合口瘘与肺部并发症增加相关(46.8% vs. 26.7%;P <0.001)。
- III型吻合口瘘与30天死亡率(7.3% vs. 2.7%)和90天死亡率(12.3% vs. 4%)升高相关(P <0.001)。
- III型吻合口瘘中位总生存期较无瘘组显著缩短(33.9 vs. 69.3个月;P <0.001)。
- 多变量调整后,III型吻合口瘘与死亡可能性增加相关(HR 1.51;95% CI: 1.04-2.18;P =0.029)。
- 吻合口瘘患者辅助治疗实施率较低(33.9% vs. 43.3%;P =0.004)。
临床怎么用
- 对需外科再干预的III型吻合口瘘患者应识别为生存高风险人群并加强围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the impact of severity of esophageal anastomotic leak (AL), standardized by ECCG grading, on long-term survival within a contemporary multicenter cohort. SUMMARY BACKGROUND DATA: Historical evidence suggesting AL is associated with increased recurrence and poor survival is limited by heterogeneous definitions and outdated management. This study utilizes the standardized ECCG definition to evaluate the prognostic significance of AL severity under modern perioperative protocols and endoscopic rescue strategies. METHODS: An international multicenter cohort across 17 high-volume European centers. Adult patients with esophageal or junctional cancer treated with neoadjuvant CROSS or FLOT, followed by esophagectomy were included (2018-2023). RESULTS: Out of 2905 patients, 425 (14.6%) developed an AL. AL was associated with a nearly two-fold increase in pulmonary complications (46.8% vs. 26.7%; P <0.001). AL requiring surgical reintervention (type III) was associated with an increased 30- and 90-days mortality rate (7.3% vs. 2.7% and 12.3% vs. 4%, P <0.001) and a significant reduction in median overall survival versus the no leak group (33.9 vs. 69.3; months P <0.001). After multivariable adjustment, type III AL was associated with a greater likelihood of death (HR 1.51; 95% CI: 1.04-2.18; P =0.029). A lower rate of adjuvant therapy administration (33.9% vs. 43.3%; P =0.004) was observe for AL patients. No significant survival deficits were observed for leaks treated conservatively or with no-surgical intervention. CONCLUSIONS: AL requiring surgical reintervention was associated with impaired survival. This relationship identifies a high-risk clinical profile and represents a critical target for future research into strategies for clinical stabilization and risk mitigation.
引用
- Giorgi L, Guidozzi N, Salem R, et al. The Impact of Anastomotic Leak After Esophagectomy on Long-term Survival in the Modern Era of Management (ALES Study): A Multicenter Cohort Study. Ann Surg. 2026. PMID: 42687130. doi:10.1097/SLA.0000000000007190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。